We have located links that may give you full text access.
Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey.
Transfusion 2016 September
BACKGROUND: Although not supported by strong evidence, premedication (pretransfusion medication) is commonly prescribed to patients who have had a transfusion reaction. The research questions were: 1) What are Canadian pediatric practitioners' views and practices regarding premedication and 2) what are barriers to reducing premedication overuse in pediatrics?
STUDY DESIGN AND METHODS: An online survey targeted hematology/oncology, emergency medicine, general surgery, intensive care, and cardiac intensive care practitioners in all 16 Canadian pediatric tertiary hospitals. The survey included four sections: demographic, clinical, future directions, and organizational questions.
RESULTS: Fifty-five individuals from 15 of 16 pediatric tertiary care sites completed the survey: 53 physicians and two nurse practitioners. More than half of the respondents (55%; 30/55) were pediatric hematology/oncology providers, and 35% (19/55) were directors of their respective divisions. Eighty-seven percent of respondents estimated that they premedicate up to 25% of red blood cell (RBC) transfusions, and 13% premedicate 26% to 50% RBC transfusions. Proportions were similar for platelet transfusions. Most respondents reported that trainees are involved in transfusion and premedication order decisions. Seven percent believe that their hospital does not use leukoreduction and 27% are not sure. Sixty-five percent of respondents were not aware of a clinical practice guideline or a standard order set (SOS) at their institution: 51% are interested in having both available. Factors influencing the decision to premedicate and barriers to change were identified.
CONCLUSION: Premedication practices are variable in Canadian pediatric academic hospitals. Evidence-based premedication clinical practice guidelines and SOS could be explored as a way to standardize practices. There were perceived educational and institutional barriers to practice change.
STUDY DESIGN AND METHODS: An online survey targeted hematology/oncology, emergency medicine, general surgery, intensive care, and cardiac intensive care practitioners in all 16 Canadian pediatric tertiary hospitals. The survey included four sections: demographic, clinical, future directions, and organizational questions.
RESULTS: Fifty-five individuals from 15 of 16 pediatric tertiary care sites completed the survey: 53 physicians and two nurse practitioners. More than half of the respondents (55%; 30/55) were pediatric hematology/oncology providers, and 35% (19/55) were directors of their respective divisions. Eighty-seven percent of respondents estimated that they premedicate up to 25% of red blood cell (RBC) transfusions, and 13% premedicate 26% to 50% RBC transfusions. Proportions were similar for platelet transfusions. Most respondents reported that trainees are involved in transfusion and premedication order decisions. Seven percent believe that their hospital does not use leukoreduction and 27% are not sure. Sixty-five percent of respondents were not aware of a clinical practice guideline or a standard order set (SOS) at their institution: 51% are interested in having both available. Factors influencing the decision to premedicate and barriers to change were identified.
CONCLUSION: Premedication practices are variable in Canadian pediatric academic hospitals. Evidence-based premedication clinical practice guidelines and SOS could be explored as a way to standardize practices. There were perceived educational and institutional barriers to practice change.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app